Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, Dull P, Plotkin SA. Earle KA, et al. Among authors: dull p. Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24. Vaccine. 2021. PMID: 34210573 Free PMC article.
Towards a population-based threshold of protection for COVID-19 vaccines.
Goldblatt D, Fiore-Gartland A, Johnson M, Hunt A, Bengt C, Zavadska D, Snipe HD, Brown JS, Workman L, Zar HJ, Montefiori D, Shen X, Dull P, Plotkin S, Siber G, Ambrosino D. Goldblatt D, et al. Among authors: dull p. Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15. Vaccine. 2022. PMID: 34933765 Free PMC article.
WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
Kristiansen PA, Page M, Bernasconi V, Mattiuzzo G, Dull P, Makar K, Plotkin S, Knezevic I. Kristiansen PA, et al. Among authors: dull p. Lancet. 2021 Apr 10;397(10282):1347-1348. doi: 10.1016/S0140-6736(21)00527-4. Epub 2021 Mar 23. Lancet. 2021. PMID: 33770519 Free PMC article. No abstract available.
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Prudden HJ, Achilles SL, Schocken C, Broutet N, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L, Gamage DG, Herrero R, Hutubessy R, Villa LL, Murillo R, Schiller JT, Stanley M, Temmerman M, Zhao F, Ogilvie G, Kaslow DC, Dull P, Gottlieb SL; Therapeutic HPV Vaccine PPC Expert Consultation Group*. Prudden HJ, et al. Among authors: dull p. Vaccine. 2022 Sep 29;40(41):5843-5855. doi: 10.1016/j.vaccine.2022.08.020. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36008233
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
Read RC, Dull P, Bai X, Nolan K, Findlow J, Bazaz R, Kleinschmidt A, McCarthy M, Wang H, Toneatto D, Borrow R. Read RC, et al. Among authors: dull p. Vaccine. 2017 Jan 11;35(3):427-434. doi: 10.1016/j.vaccine.2016.11.071. Epub 2016 Nov 29. Vaccine. 2017. PMID: 27912986 Free article. Clinical Trial.
96 results